Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2

被引:180
作者
Higginbottom, A
Quinn, ER
Kuo, CC
Flint, M
Wilson, LH
Bianchi, E
Nicosia, A
Monk, PN
McKeating, JA
Levy, S [1 ]
机构
[1] Stanford Univ, Med Ctr, Dept Med, Div Oncol, Stanford, CA 94305 USA
[2] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2UH, S Yorkshire, England
[3] Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England
[4] IRBM, I-00040 Pomezia, Rome, Italy
基金
英国惠康基金;
关键词
D O I
10.1128/JVI.74.8.3642-3649.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human CD81 has been previously identified as the putative receptor for the hepatitis C virus envelope glycoprotein E2. The large extracellular loop (LEL) of human CD81 differs in four amino acid residues from that of the African green monkey (AGM), which does not bind E2, We mutated each of the four positions inhuman CD81 to the corresponding AGM residues and expressed them as soluble fusion LEL proteins in bacteria or as complete membrane proteins in mammalian cells. We found human amino acid 186 to be critical for the interaction,vith the viral envelope glycoprotein, This residue was also important for binding of certain anti-CD81 monoclonal antibodies, Mutating residues 188 and 196 did not affect E2 or antibody binding. Interestingly, mutation of residue 163 increased both E2 and antibody binding, suggesting that this amino acid contributes to the tertiary structure of CD81 and its ligand-binding ability. These observations have implications for the design of soluble high-affinity molecules that could target the CD81-E2 interaction site(s).
引用
收藏
页码:3642 / 3649
页数:8
相关论文
共 17 条
  • [1] A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2
    Cocquerel, L
    Meunier, JC
    Pillez, A
    Wychowski, C
    Dubuisson, J
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (03) : 2183 - 2191
  • [2] THE CD19/CR2/TAPA-1 COMPLEX OF B-LYMPHOCYTES - LINKING NATURAL TO ACQUIRED-IMMUNITY
    FEARON, DT
    CARTER, RH
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1995, 13 : 127 - 149
  • [3] Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81
    Flint, M
    Maidens, C
    Loomis-Price, LD
    Shotton, C
    Dubuisson, J
    Monk, P
    Higginbottom, A
    Levy, S
    McKeating, JA
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (08) : 6235 - 6244
  • [4] SITE-DIRECTED MUTAGENESIS BY OVERLAP EXTENSION USING THE POLYMERASE CHAIN-REACTION
    HO, SN
    HUNT, HD
    HORTON, RM
    PULLEN, JK
    PEASE, LR
    [J]. GENE, 1989, 77 (01) : 51 - 59
  • [5] IMAI T, 1995, J IMMUNOL, V155, P1229
  • [6] CD81 (TAPA-1): A molecule involved in signal transduction and cell adhesion in the immune system
    Levy, S
    Todd, SC
    Maecker, HT
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 : 89 - 109
  • [7] THE MEASUREMENT OF RELATIVE ANTIBODY-AFFINITY BY ELISA USING THIOCYANATE ELUTION
    MACDONALD, RA
    HOSKING, CS
    JONES, CL
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 106 (02) : 191 - 194
  • [8] The tetraspanin superfamily: Molecular facilitators
    Maecker, HT
    Todd, SC
    Levy, S
    [J]. FASEB JOURNAL, 1997, 11 (06) : 428 - 442
  • [9] HEPATITIS-C VIRUS-INFECTION IN PATIENTS WITH ESSENTIAL MIXED CRYOGLOBULINEMIA
    MISIANI, R
    BELLAVITA, P
    FENILI, D
    BORELLI, G
    MARCHESI, D
    MASSAZZA, M
    VENDRAMIN, G
    COMOTTI, B
    TANZI, E
    SCUDELLER, G
    ZANETTI, A
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 117 (07) : 573 - 577
  • [10] TAPA-1, THE TARGET OF AN ANTIPROLIFERATIVE ANTIBODY, DEFINES A NEW FAMILY OF TRANSMEMBRANE PROTEINS
    OREN, R
    TAKAHASHI, S
    DOSS, C
    LEVY, R
    LEVY, S
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (08) : 4007 - 4015